GHISELLI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 7.736
EU - Europa 3.728
AS - Asia 3.560
SA - Sud America 759
AF - Africa 226
Continente sconosciuto - Info sul continente non disponibili 160
OC - Oceania 11
Totale 16.180
Nazione #
US - Stati Uniti d'America 7.583
SG - Singapore 1.348
RU - Federazione Russa 634
VN - Vietnam 628
UA - Ucraina 626
BR - Brasile 581
CN - Cina 544
IT - Italia 490
DE - Germania 351
SE - Svezia 346
IE - Irlanda 331
TR - Turchia 282
HK - Hong Kong 270
FR - Francia 248
DK - Danimarca 234
FI - Finlandia 213
KR - Corea 126
GB - Regno Unito 118
CI - Costa d'Avorio 113
BD - Bangladesh 77
IN - India 66
CA - Canada 62
AR - Argentina 59
MX - Messico 57
IQ - Iraq 36
ZA - Sudafrica 34
MA - Marocco 33
CO - Colombia 30
JP - Giappone 29
NL - Olanda 29
EC - Ecuador 27
ID - Indonesia 22
PL - Polonia 21
PK - Pakistan 19
VE - Venezuela 19
UZ - Uzbekistan 18
BE - Belgio 16
ES - Italia 16
AT - Austria 13
MY - Malesia 13
CL - Cile 12
PH - Filippine 12
PY - Paraguay 12
CR - Costa Rica 10
OM - Oman 9
PE - Perù 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
JO - Giordania 8
RO - Romania 8
SA - Arabia Saudita 8
EG - Egitto 7
UY - Uruguay 7
ET - Etiopia 6
KE - Kenya 6
KZ - Kazakistan 6
LT - Lituania 6
DO - Repubblica Dominicana 5
AL - Albania 4
AU - Australia 4
BG - Bulgaria 4
DZ - Algeria 4
EU - Europa 4
PA - Panama 4
PS - Palestinian Territory 4
AZ - Azerbaigian 3
HR - Croazia 3
IR - Iran 3
LB - Libano 3
NI - Nicaragua 3
SN - Senegal 3
AO - Angola 2
BO - Bolivia 2
CG - Congo 2
CH - Svizzera 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
JM - Giamaica 2
KI - Kiribati 2
NP - Nepal 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CV - Capo Verde 1
DM - Dominica 1
FJ - Figi 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
Totale 16.008
Città #
Ashburn 1.232
Singapore 808
Jacksonville 623
Chandler 568
Fairfield 442
Dallas 396
San Jose 390
Dublin 331
Boardman 293
Hong Kong 260
Wilmington 246
Council Bluffs 242
Woodbridge 225
New York 217
Ho Chi Minh City 212
Seattle 189
Houston 174
Moscow 154
Hanoi 150
Beijing 140
Ann Arbor 139
Princeton 133
Lawrence 131
San Mateo 127
Cambridge 120
Lauterbourg 115
The Dalles 115
Abidjan 113
Los Angeles 97
Hefei 81
Des Moines 71
Munich 68
Buffalo 64
Turin 64
San Diego 52
São Paulo 52
Helsinki 50
Centro 49
Santa Clara 49
Turku 44
Orem 39
Da Nang 32
Milan 32
London 26
Mexico City 26
Chicago 25
Denver 23
Guangzhou 23
Shanghai 23
Haiphong 21
Johannesburg 21
Tokyo 21
Miano 20
Montreal 19
Chennai 18
Rome 18
Tashkent 18
Warsaw 18
Porto 17
Atlanta 16
Baghdad 16
Brasília 16
Brussels 15
Nuremberg 14
Ottawa 14
Phoenix 14
Rio de Janeiro 14
Izmir 13
Norwalk 13
Pune 13
Biên Hòa 12
Columbus 12
Manchester 12
Redmond 12
Washington 12
Belo Horizonte 11
Brooklyn 11
Buenos Aires 11
Guayaquil 11
Wuhan 11
Amsterdam 10
Ancona 10
Campinas 10
Falls Church 10
Fermo 10
Jakarta 10
Kilburn 10
Poplar 10
Ankara 9
Can Tho 9
Karachi 9
Salt Lake City 9
Stockholm 9
Curitiba 8
Dhaka 8
Dronten 8
Hải Dương 8
Mumbai 8
Boston 7
Caracas 7
Totale 9.918
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 334
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 268
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 232
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 209
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 202
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 200
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 197
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 186
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 185
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 173
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 172
Anastomotic healing in a rat model of peritonitis after non-steroidal anti-inflammatory drug administration. 170
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 166
Minimally invasive approach to the adrenal gland in obese patients with Cushing’s syndrome 163
Is the bipolar vessel sealer device an effective tool in robotic surgery? A retrospective analysis of our experience and a meta-analysis of the literature about different robotic procedures by investigating operative data and post-operative course 162
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 162
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 157
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 155
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 153
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 152
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 151
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 151
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 148
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 147
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 145
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 144
Transanal endoscopic microsurgery: indications, tips and long-term results. A single center experience 144
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 143
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 142
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 142
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 140
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 140
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 139
Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation 139
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 138
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 135
Increase of n-NOS and i-NOS in Rat Colon After Sacral Neuromodulation 135
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 134
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 134
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 133
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 133
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 133
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 132
Transanal endoscopic microsurgery as optimal option in treatment of rare rectal lesions: A single centre experience. 132
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 131
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 130
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 128
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 127
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 127
Treatment of rectal cancer by transanal endoscopic microsurgery: experience with 425 patients. 127
The biocompatibility of dibutyryl chitin in the context of wound dressings. 127
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 127
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 125
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 125
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 125
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 124
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 124
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 123
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 123
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 123
Urinary catheters and biofilm formation 122
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 122
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 121
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 120
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 119
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 119
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 118
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 117
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 116
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 116
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 115
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 115
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 115
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. 115
LL-37 protects rats against lethal gram-negative sepsis. 113
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 113
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 112
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 111
Totally robotic vs 3D laparoscopic colectomy: A single centers preliminary experience 109
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 108
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 107
Transanal endoscopic microsurgery in the treatment of large rectal adenomas. 106
Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation 106
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 105
Efficacy of LL-37 and Granulocyte-Colony Stimulating Factor in a Neutropenic Murine Sepsis due to Pseudomonas aeruginosa 104
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 103
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 102
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 101
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 101
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 100
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 100
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 100
Nitric Oxide Synthase Expression in Rat Anorectal Tissue after Sacral Neuromodulation 99
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 99
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. 98
Robotic versus laparoscopic right colectomy for cancer: short-term outcomes and influence of Body Mass Index on conversion rate. 98
Laparoscopic repair of giant Morgagni hernia by direct suturing with V-Loc. 98
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 97
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. 97
Prevention of hernia incision in laparoscopic left colon resection. 96
Totale 13.501
Categoria #
all - tutte 72.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022961 0 228 10 52 22 71 45 51 65 125 86 206
2022/20231.767 182 197 138 134 128 211 3 100 443 13 159 59
2023/2024975 175 21 59 145 168 253 17 20 5 13 14 85
2024/20252.426 283 190 131 123 104 159 249 113 455 118 247 254
2025/20265.766 371 479 435 587 569 406 992 584 555 436 124 228
2026/2027386 239 147 0 0 0 0 0 0 0 0 0 0
Totale 16.180